Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Oluchi C. Ukaegbu"'
Autor:
Paremeswaran Hari, Murat O. Arcasoy, John Mascarenhas, Ahmad Hanif, Donal P. McLornan, James O.J. Davies, Rebecca B. Klisovic, Srdan Verstovsek, Usama Gergis, Navneet S. Majhail, Vikas Gupta, Brenda Ernst, Uday R. Popat, Eshetu G. Atenafu, Richard E. Champlin, Sumithira Vasu, Veena Fauble, Rizwan Romee, Mohamed Shanavas, Oluchi C. Ukaegbu, John M. Storring, Antonio Pagliuca, Laura C. Michaelis, Rammurti T. Kamble, Roni Tamari
The impact of Janus kinase (JAK) 1/2 inhibitor therapy before allogeneic hematopoietic cell transplantation (HCT) has not been studied in a large cohort in myelofibrosis (MF). In this retrospective multicenter study, we analyzed outcomes of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b771fb7b635df1b73c6dd1795495784
https://europepmc.org/articles/PMC5030817/
https://europepmc.org/articles/PMC5030817/
Autor:
Rebecca R. Hung, Madan Jagasia, Oluchi C. Ukaegbu, Tarsheen K. Sethi, Stacey Goodman, Robert F. Cornell, David Slosky, Adetola A. Kassim, Samuel M. Rubinstein, Daniel J. Lenihan, Shelton Lacy, Anthony Langone, Bipin N. Savani
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S233-S234
Autor:
Oluchi C Ukaegbu
Publikováno v:
Journal of Blood Disorders & Transfusion.
Autor:
Ilka Decker, Sharon Phillips, Stacey Goodman, Kevin T. McDonagh, Samuel M. Rubinstein, Robert F. Cornell, Shelton L. Harrell, Tarsheen K. Sethi, Oluchi C. Ukaegbu, Daniel J. Lenihan, Rebecca Hung, Kyle T Rawling, Adetola A. Kassim
Publikováno v:
Blood. 126:1841-1841
Background: Light chain amyloidosis (AL) is characterized by tissue deposition of misfolded proteins that cause multisystem organ dysfunction. Current treatments, including chemotherapy and autologous hematopoietic cell transplantation (AHCT), target
Autor:
Oluchi C. Ukaegbu, Javid Moslehi, Madan Jagasia, Kevin T. McDonagh, Robert F. Cornell, Shelton Lacy, David Slosky, Tarsheen K. Sethi, Adetola A. Kassim, Stacey Goodman, Sharon Phillips, John H. Chen, Daniel J. Lenihan
Publikováno v:
Blood. 126:5363-5363
Introduction Proteasome inhibitors (PI) bortezomib (B) and carfilzomib (C) are cornerstone therapies for multiple myeloma (MM). An increased incidence of PI-induced cardiac adverse events (CAEs) has been reported in patients receiving C. However, ris
Autor:
Anthony Langone, Rebecca Hung, Robert F. Cornell, Stacey Goodman, Kevin T. McDonagh, Sara N. Horst, Samuel M. Rubinstein, Ilka Decker, Mark P. Steele, Oluchi C. Ukaegbu, Kyle T Rawling, Daniel J. Lenihan, Sharon Phillips, Robert D. Hoffman, Adetola A. Kassim, Shelton Lacy
Publikováno v:
Journal of Clinical Oncology. 33:e19539-e19539
e19539 Background: Light chain amyloidosis (AL) is characterized by the accumulation of misfolded proteins that deposit in tissue causing multisystem organ dysfunction. Current treatments target pl...
Autor:
Stacey Goodman, Bipin N. Savani, Wichai Chinratanalab, LaQuisa Hill, Oluchi C. Ukaegbu, Stephen J. Brandt, Salyka Sengsayadeth
Publikováno v:
Blood. 124:1125-1125
Early lymphocyte recovery (ELC) is associated with improved outcomes of hematologic malignancies after autologous hematopoietic stem cell transplantation (auto-SCT). ELC, its composition and impact on outcome depends on many variables; however there